Dr Leila Equinet United States

L'INPI est un établissement public, entièrement autofinancé, placé sous la tutelle du ministère de l'Économie, de l'Industrie et du Numérique.

Il délivre les brevets, marques, dessins et modèles et donne accès à toute l'information sur la propriété industrielle et les entreprises.

Il participe activement à l'élaboration et à la mise en œuvre des politiques publiques dans le domaine de la propriété industrielle et de la lutte anti-contrefaçon.

INPI
IP counselor 

Mr Ryan Erwin United States

Seamless access to critical data. Customer support that never stops. 21st-century ingenuity combined with good old-fashioned integrity. That's Accessium. No matter what business you're in, our custom solutions will take your data efficiency and security to the next level.

Specialties

PACS/Radiology/Cardiac/Ortho Systems, HealthCare Information Technology, Moblie Application Integration, Network Security/Auditing, Server and Network Architecture/Design/Support

Accessium Group Inc.
LinkedIn logo CEO 

Aaron Etra United States

At ILSC, we believe that collaboration and innovation are the best ways to tackle the world’s most pressing health challenges. As a result, we strive to encourage and enhance the development of innovative initiatives and collaborative approaches. To achieve our mission, we have formed strong partnerships with leading experts, academic institutions, organizations, and key stakeholders, including Yale UniversityIBMUNA-USACIMIT, and the Climate Remediation Foundation. Through our collaborations, we aim to make meaningful and measurable improvements in the global healthcare landscape.

Institute for Life Sciences Collaboration
LinkedIn logo , Secretary & Treasurer 

Mr Artem Evdokimov United States

HarkerBIO possesses unique capabilities that accelerate the development of new drugs. 

HarkerBIO is located on the growing Buffalo Niagara Medical Campus, a consortium of the region's premier health care, life sciences research, and medical education institutions, all located on 120 acres in downtown Buffalo, New York.

Specialties

biomolecular crystallization

HarkerBIO
Chief Scientific Officer 

Ms BĂ©atrice Falise-Mirat France

Are you seeking to develop your R&D skills, enhance your innovation potential and increase your business opportunities ? Check how Medicen Paris Region can help you.

MEDICEN
CEO 

Ms Betsy Farrell United States

NYU Langone Medical Center is one of the nation’s premier academic medical centers. Our trifold mission to serve, teach, and discover is achieved daily through an integrated academic culture devoted to excellence in patient care, education, and research.Located in the heart of Manhattan, with additional facilities throughout the New York City area, NYU Langone consists of four hospitals:

NYU Langone Medical Center
Facilities Manager, Research/Education Portfolios 

Mr Thomas Ferro United States

Global Orthopedic Network, Inc.
LinkedIn logo President 

Miss Sydney FLEURANCE United States

The VIE Program is a hassle-free HR package offered by the French government which allows your company to recruit highly skilled young professionals from Europe.  It is entirely flexible and comes with many financial advantages, which explains why the program is so successful. There are currently 8200 VIEs assigned in 1800 companies worldwide and the US is the #1 destination with more than 1000 VIEs currently assigned.

VIE Program - BusinessFrance
Project Manager 

Dr JoAnne Foody United States

From developing new therapies that treat and prevent disease to helping people in need, we're committed to improving health and well-being around the world.
Merck & Co., Inc.
Global Director for Scientific Affairs, Cardiovascular 

Mr Dennis Ford United States

Life Science Nation (LSN) was founded by Dennis Ford, CEO, in 2012 to bring a better sales and marketing awareness to the life science community. LSN’s goal is to educate scientists in the basic skills required to brand, message, and market their companies.

Before LSN, Dennis was the CEO of a company that pioneered a system for uncovering global institutional investors and gauging their appetite regarding investing in hedge funds, private equity funds, and venture capital (VC) funds. The methodology used to capture and curate this valuable data was developed in part by a research team that would cold call and canvass these investors. The team would conduct a one-on-one interview with each investor that uncovered any current investment mandates they had. This allowed them to identify exactly where the capital was and specifically who had the mandate to deploy it.

After working with fundraisers in the alternative finance space for six years, Dennis wanted to bring his expertise to the life sciences and channel this fundraising experience toward the goal of moving science forward. Dennis knew from his experience in the alternatives field that many institutional investors and family offices were starting to withdraw capital from funds due to a decade of sub-par returns, initiating a trend of direct investment. This dovetailed with an accelerating trend of philanthropic investment and a desire among many investors to eradicate diseases affecting their family, friends or other groups that they have an affinity towards.

Identifying who has capital and is a fit for your company is the conundrum of the life science arena. The life science industry is poised at the entryway of a new golden age.  The one factor holding back the life science explosion is lack of capital. Dennis’s vision led him to believe that LSN could expedite the capital-raising problem by identifying active life science investors seeking emerging biotech and medtech companies and creating in-depth profiles that detail their specific preferences.  This would allow scientist-entrepreneurs to identify investors based on fit for their stage and sector, thus greatly enhancing the results of their outbound fundraising campaigns.

Dennis sought to create a match.com-like sourcing platform for the life sciences.  He knew that he needed not only current, accurate, and actionable information on both of the constituent groups who would use the platform, but also a home for the data he had started to gather on early stage life science investors.

Life Science Nation
CEO